On September 6, 2022 Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, reported Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences (Press release, Biodesix, SEP 6, 2022, View Source [SID1234619083]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Morgan Stanley 20th Annual Global Healthcare Conference
Date: Tuesday, September 13, 2022 at 9:10 a.m. ET
Format: Fireside Chat and 1×1 meetings
Location: Sheraton Hotel, New York, NY
Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company’s website at www.biodesix.com.
H.C. Wainwright 24th Annual Global Investment Conference
Dates: September 12-14, 2022
Format: 1×1 meetings
Location: Lotte New York Palace Hotel, New York, NY